These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7117370)

  • 41. Pharmacological characterization of serotonin receptors in the facial motor nucleus: a microiontophoretic study.
    McCall RB; Aghajanian GK
    Eur J Pharmacol; 1980 Jul; 65(2-3):175-83. PubMed ID: 7398786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sleep suppressant action of quipazine: relation to central serotonergic stimulation.
    Fornal C; Radulovacki M
    Pharmacol Biochem Behav; 1981 Dec; 15(6):937-44. PubMed ID: 7323120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
    Vaatstra WJ; Deiman-Van Aalst WM; Eigeman L
    Eur J Pharmacol; 1981 Mar; 70(2):195-202. PubMed ID: 6973481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of suckling in weaning-age rats: a possible serotonergic mechanism.
    Williams CL; Rosenblatt JS; Hall WG
    J Comp Physiol Psychol; 1979 Jun; 93(3):414-29. PubMed ID: 479391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of quipazine and D-fenfluramine, two serotonin-like drugs, on TSH secretion in basal and cold stimulated conditions in the rat.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1978 Jun; 22(21):1879-85. PubMed ID: 672433
    [No Abstract]   [Full Text] [Related]  

  • 48. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection.
    Ung RV; Landry ES; Rouleau P; Lapointe NP; Rouillard C; Guertin PA
    Eur J Neurosci; 2008 Dec; 28(11):2231-42. PubMed ID: 19019202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus.
    Van de Kar LD; Bethea CL
    Neuroendocrinology; 1982 Oct; 35(4):225-30. PubMed ID: 7145018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible dopamine agonist properties of quipazine maleate.
    Feigenbaum JJ; Yanai J; Klawans HL
    Int J Neurosci; 1983; 18(3-4):205-10. PubMed ID: 6222999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonin 5-HT2 receptors induce a long-lasting facilitation of spinal reflexes independent of ionotropic receptor activity.
    Shay BL; Sawchuk M; Machacek DW; Hochman S
    J Neurophysiol; 2005 Oct; 94(4):2867-77. PubMed ID: 16033939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
    Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
    [No Abstract]   [Full Text] [Related]  

  • 54. Serotonin-induced in vitro long-term facilitation exhibits differential pattern sensitivity in cervical and thoracic inspiratory motor output.
    Lovett-Barr MR; Mitchell GS; Satriotomo I; Johnson SM
    Neuroscience; 2006 Oct; 142(3):885-92. PubMed ID: 16893610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.
    Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA
    Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotoninergic and non-serotoninergic responses of phrenic motoneurones to raphe stimulation in the cat.
    Lalley PM
    J Physiol; 1986 Nov; 380():373-85. PubMed ID: 3612566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-lasting synaptic facilitation induced by serotonin in superficial dorsal horn neurones of the rat spinal cord.
    Hori Y; Endo K; Takahashi T
    J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):867-76. PubMed ID: 8734996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents.
    Nacca A; Guiso G; Fracasso C; Cervo L; Caccia S
    Br J Pharmacol; 1998 Dec; 125(7):1617-23. PubMed ID: 9884092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.